DC Field | Value | Language |
---|---|---|
dc.contributor.author | Park, SH | ko |
dc.contributor.author | Kang, HJ | ko |
dc.contributor.author | Ko, S | ko |
dc.contributor.author | Park, S | ko |
dc.contributor.author | Chang, Sukbok | ko |
dc.date.accessioned | 2013-03-03T11:51:19Z | - |
dc.date.available | 2013-03-03T11:51:19Z | - |
dc.date.created | 2012-02-06 | - |
dc.date.created | 2012-02-06 | - |
dc.date.issued | 2001-10 | - |
dc.identifier.citation | TETRAHEDRON-ASYMMETRY, v.12, no.18, pp.2621 - 2624 | - |
dc.identifier.issn | 0957-4166 | - |
dc.identifier.uri | http://hdl.handle.net/10203/78539 | - |
dc.description.abstract | (-)-Coniceine, the simplest framework of indolizidine alkaloids. has been successfully accessed using a route in which ruthenium-catalyzed ring-closing olefin metathesis (RCM) was the key reaction to establish the unsaturated bicyclic lactam system. (C) 2001 Elsevier Science Ltd. All rights reserved. | - |
dc.language | English | - |
dc.publisher | PERGAMON-ELSEVIER SCIENCE LTD | - |
dc.title | A short and concise synthetic route to (-)-coniceine | - |
dc.type | Article | - |
dc.identifier.wosid | 000172642400018 | - |
dc.identifier.scopusid | 2-s2.0-0035888827 | - |
dc.type.rims | ART | - |
dc.citation.volume | 12 | - |
dc.citation.issue | 18 | - |
dc.citation.beginningpage | 2621 | - |
dc.citation.endingpage | 2624 | - |
dc.citation.publicationname | TETRAHEDRON-ASYMMETRY | - |
dc.identifier.doi | 10.1016/S0957-4166(01)00446-3 | - |
dc.contributor.localauthor | Chang, Sukbok | - |
dc.contributor.nonIdAuthor | Park, SH | - |
dc.contributor.nonIdAuthor | Kang, HJ | - |
dc.contributor.nonIdAuthor | Ko, S | - |
dc.contributor.nonIdAuthor | Park, S | - |
dc.type.journalArticle | Article | - |
dc.subject.keywordPlus | OLEFIN METATHESIS | - |
dc.subject.keywordPlus | INDOLIZIDINE | - |
dc.subject.keywordPlus | (+/-)-DELTA-CONICEINE | - |
dc.subject.keywordPlus | GENERATION | - |
dc.subject.keywordPlus | ALKALOIDS | - |
dc.subject.keywordPlus | ACID | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.